Literature DB >> 26507538

Control of Anticoagulation With Warfarin or Acenocoumarol in Spain. Do They Differ?

Vivencio Barrios1, Carlos Escobar2, Luis Prieto3, José María Lobos4, José Polo5, Diego Vargas6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26507538     DOI： 10.1016/j.rec.2015.07.024

Source DB:  PubMed          Journal:  Rev Esp Cardiol (Engl Ed)        ISSN： 1885-5857


× No keyword cloud information.
  4 in total

1.  Periodontal and biochemical bone metabolism assessment on a chronic oral anticoagulation population treated with dicoumarins.

Authors:  D López-Lacomba; A Roa-López; M González-Jaranay; G Gómez-Moreno; G Moreu
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2017-03-01

2.  Cost of incorrect application of antithrombotic prophylaxis prior to invasive procedures.

Authors:  Ma Victoria Cuevas; Ignacio Martínez-Sancho; Jana Arribas; Covadonga García-Díaz; Beatriz Cuevas
Journal:  BMC Health Serv Res       Date:  2019-11-06       Impact factor: 2.655

3.  Cost-effectiveness analysis of apixaban versus vitamin K antagonists for antithrombotic therapy in patients with atrial fibrillation after acute coronary syndrome or percutaneous coronary intervention in Spain.

Authors:  Simone Rivolo; Manuela Di Fusco; Carlos Polanco; Amiee Kang; Devender Dhanda; Mirko Savone; Aristeidis Skandamis; Thitima Kongnakorn; Javier Soto
Journal:  PLoS One       Date:  2021-11-12       Impact factor: 3.240

4.  Anticoagulation Control with Acenocoumarol or Warfarin in Non-Valvular Atrial Fibrillation in Primary Care (Fantas-TIC Study).

Authors:  M Rosa Dalmau Llorca; Carina Aguilar Martín; Noèlia Carrasco-Querol; Zojaina Hernández Rojas; Emma Forcadell Drago; Dolores Rodríguez Cumplido; Elisabet Castro Blanco; Alessandra Queiroga Gonçalves; José Fernández-Sáez
Journal:  Int J Environ Res Public Health       Date:  2021-05-26       Impact factor: 3.390
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.